Project Grant HT9425261E172
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94305, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Palo Alto Veterans Institute For Research (Pavir) a $1.163 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2029. The award funds research investigating endothelial-to-mesenchymal transition and cardiovascular disease in veterans exposed to burn pit emissions through advanced imaging techniques and three-dimensional heart tissue models....
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Stanford University a $832,270 Project Grant effective July 1, 2025, through June 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports high-throughput in vivo lung cancer pharmacogenomics research conducted at Stanford's Palo Alto, California facility. This research initiative will deliver advanced biomedical research services focused on investigating innovative medical...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1.82M project grant effective May 1, 2026, through April 30, 2030, under the Military Medical Research and Development program (CFDA 12.420). The award supports development of a predictive spatial assay designed to eliminate unnecessary therapeutic interventions in primary ductal carcinoma in situ (DCIS), a form of breast cancer. This research initiative represents a translational...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $1,054,071 under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. This award supports the development of novel inhibitors of NEMO-like kinase for the treatment of Diamond Blackfan Anemia, a rare hematologic disorder. Research will be conducted at Stanford's Palo Alto, California facility over...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1.528 million project grant on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to develop a predictive spatial assay for eliminating unnecessary therapies in primary ductal carcinoma in situ (DCIS). The four-year award, with an ultimate completion date of April 30, 2030, supports advanced biomedical research aimed at improving cancer...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $3,128,801 under the Military Medical Research and Development program (CFDA 12.420) to develop a blood test for measuring sleep deprivation and circadian time. The award, effective June 1, 2025, through May 31, 2028, supports advanced biomedical research directed at transforming healthcare for military service members and the broader public. This research initiative...
- This federal Project Grant award of $430,513.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at The Leland Stanford Junior University (Stanford University) to understand how vascular endothelial cells regulate fibroblast functions in pancreatitis. The award, with a period of performance from March 1, 2025 to February 28, 2027, will enable Stanford University to conduct advanced biomedical research focused on transforming...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $7.0 million Project Grant on April 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support the TAILORX Clinical Research Extension Award: Advancing Breast Cancer Treatment Stratification Through Spatial Omics and Digital Pathology. The four-year award, with a completion date of April 14, 2030, will be performed at Stanford's Palo Alto, CA location...
- This Project Grant award of $2,209,988.00 from the Defense Health Agency supports research by The Leland Stanford Junior University, doing business as Stanford University, to develop pharmacological approaches for protection and recovery from burn-associated inhalation injury. The research is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for service members and the public. Over the award period from...
- Federal Grant Award Summary The Defense Health Agency awarded The Leland Stanford Junior University a $604,151 Project Grant on May 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on therapeutic inactivation of the MYC oncogene as a treatment for triple negative breast cancer. The three-year research initiative, scheduled for completion by May 14, 2029, will be conducted at Stanford's Palo Alto, California facility. This award supports...